Anna Czarnecka

Depressive-like neurochemical and behavioral markers of Parkinson’s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle

Kinga Kamińska, Tomasz Lenda, Jolanta Konieczny et al. · Pharmacological Reports · 2017 · 55 citations

Life Sciences, Neurobiology, Neuroscience +16

Lack of Neuroprotective Effect of Celastrol Under Conditions of Proteasome Inhibition by Lactacystin in In Vitro and In Vivo Studies: Implications for Parkinson’s Disease

Jolanta Konieczny, Danuta Jantas, Tomasz Lenda et al. · Neurotoxicity Research · 2014 · 42 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Persistent Overexposure to N-Methyl-d-Aspartate (NMDA) Calcium-Dependently Downregulates Glutamine Synthetase, Aquaporin 4, and Kir4.1 Channel in Mouse Cortical Astrocytes

Katarzyna Skowrońska, Marta Obara‐Michlewska, Anna Czarnecka et al. · Neurotoxicity Research · 2018 · 33 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA

Elżbieta Lorenc‐Koci, Anna Czarnecka, Tomasz Lenda et al. · Neurochemistry International · 2013 · 27 citations

Life Sciences, Neuroscience, Pharmacology +17

Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine

Anna Czarnecka, Tomasz Lenda, Helena Domin et al. · Brain Research · 2013 · 25 citations

Life Sciences, Neurobiology, Neuroscience +17